The two drugs, vopimetostat from Tango Therapeutics and daraxonrasib from Revolution Medicines, will...
Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
The two drugs, vopimetostat from Tango Therapeutics and daraxonrasib from Revolution Medicines, will now be tested in a Phase 3 trial.
Author: statnews.com
Read Original Article